Please login to the form below

Not currently logged in
Email:
Password:

Tabalumab

This page shows the latest Tabalumab news and features for those working in and with pharma, biotech and healthcare.

Lilly reports first pivotal data for Xeljanz rival in arthritis

Lilly reports first pivotal data for Xeljanz rival in arthritis

Meanwhile, the positive data for baricitinib in RA is a boost for Lilly's anti-inflammatory portfolio, which suffered a casualty in October when tabalumab was dropped from development.

Latest news

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics